When the Iraq hospital I visited in late 2025 couldn't answer "what do you need?", it pointed to something more than that single conversation. A framework for thinking about what to invest in was missing. But so was something more specific: a clear picture of what the market itself could actually absorb. Earlier this year I sat down with someone who sells imaging equipment — X-ray, CT, MRI — into Iraqi hospitals, to find out.

The answer was not what I expected.

The binding constraint in Iraq's medical imaging market is not demand. It is not technology. It is not even the absence of willing buyers. It is the financing structure beneath the market, and the pricing ceilings that structure produces.

The shape of the market

Iraq has roughly 300 public hospitals and about 100 private ones. The system runs about 80% public and 20% private. Per-patient health spending is approximately $100–200 per year — far below Jordan's ~$400 and an order of magnitude below the UAE's ~$2,000.

• 80/20Public/private system split
• $100–200Per-patient annual spend (vs. $2K UAE)
• 10–15Private hospitals considered high quality (out of ~100)

The public sector dominates equipment demand. In the supplier's own example, ten X-ray units sold split roughly eight public, two private. Spending decisions in the public system are dictated by the Ministry of Health, which uses external benchmarks like ECRI to evaluate technical standards. Price matters less to them than specifications.

The private market is more fragmented than the hospital count suggests. Of the roughly 100 private hospitals, only about 10 to 15 are considered high quality. The rest operate with older and often used equipment, frequently far older than regulation allows. They cannot afford new machines because their economics don't support it — and the economics don't support it because of a specific problem with how the market prices scans.

The pricing ceiling problem

Manufacturing cost for imaging equipment is roughly similar globally. Return on investment in Iraq is worse than in most places for two reasons: lower prices and lower volume.

A procedure like kidney stone removal costs $30,000 to $40,000 in the United States. In Iraq, it costs $1,000 to $2,000. That price reflects what the market can bear. But within imaging specifically, there is a structural dynamic that compounds the problem: the prevalence of older, used equipment establishes a pricing ceiling.

A private hospital operating a twenty-year-old CT scanner charges roughly $100 per scan. A hospital that wants to buy a new machine cannot charge meaningfully more for the same procedure, because patients and referring physicians will simply route to the cheaper provider. The new machine delivers better image quality, better diagnostic capability, and lower radiation dose — but in a fragmented market with limited insurance coverage, none of those benefits translate into pricing power.

The payback period on a new imaging machine in Iraq stretches to nine or ten years. That is a long time to wait in a country where policy, exchange rates, and political conditions can change inside of two.

Insurance and the slow unlock

Iraq introduced a formal health insurance system roughly two years ago. It is still early. Currently, only about 40 to 50 private hospitals qualify to participate, funded through the Ministry of Health, with employee contributions of around $5 per month.

The expectation, according to the supplier, is that public hospitals may move toward a similar funding model within five years. If that happens, and if insurance coverage scales along with it, several things change at once. Hospitals gain predictable revenue against which they can finance new equipment. The pricing ceiling lifts because insured patients can afford higher-quality care at prices that support better-equipped providers. Payback periods shorten. New equipment starts making economic sense.

None of this requires new technology, new training pipelines, or new hospital construction. The underlying system exists. What is missing is the financial plumbing that would allow it to operate at the quality level its workforce and institutions are capable of delivering.

What this tells us about Iraq's three-axis classification

This case study is the reason Iraq sits at Medium capital allocation, Yellow (mixed) policy alignment, Advanced system sophistication rather than at higher capital ratings where oil-wealth assumptions might place it. Institutions, workforce, and procurement processes are sophisticated. Capital reaching the system is moderate and unevenly distributed between public and private. Policy is moving in the right direction — insurance reform, expanded private-hospital participation — but the environment is still volatile enough that ten-year payback periods are hard to justify.

The sophistication is there. Iraq has 300 public hospitals. It has procurement processes that reference international benchmarks. It has trained physicians, many foreign-educated. It has 10 to 15 private hospitals operating at quality levels comparable to regional peers. It has the beginnings of an insurance system. These are not the features of a low-sophistication health system.

But the resources reaching that system are low. Per-patient spending is a fraction of neighboring countries. Private hospital economics don't support reinvestment. Payback periods stretch into a decade. And new equipment — even when hospitals want it — often can't be financed through conventional means, because banks in Iraq lend against hospital operations, not against the equipment itself.

That single line from the supplier does more work than most of what you can read about the Iraqi health system in policy reports. The equipment can be procured. The demand is there. The technical standards exist. But without financing structures that match the cash flow reality of Iraqi hospitals, the gap between what the system could do and what it actually does stays wide.

Investment implications

For anyone deploying capital into Iraqi health infrastructure, three things follow from this case study:

Equipment donations alone will not move the quality ceiling. Giving a hospital a new CT scanner doesn't change the pricing dynamics that determined why it had an old one in the first place. A new machine operated at old-machine prices still produces old-machine economics. Capital directed at equipment needs to travel alongside the financing or insurance infrastructure that makes the equipment economically viable to operate.

Financing infrastructure is a high-leverage intervention. The supplier described hospitals preferring two-to-three-year installment plans but no strong equipment-financing infrastructure to provide them. Banks finance hospital operations but not equipment directly. Building or backing an equipment-financing mechanism in Iraq would unlock demand that currently exists but cannot transact. This is a less visible intervention than funding a hospital wing, and it is probably more impactful.

Insurance scaling is the slow, structural unlock. The transition to a broader insurance-based funding model, if it continues, will reshape what the market can absorb. Investors and operators who position early — by building relationships with hospitals that will be part of that transition, or by investing in the financing layer that will service it — stand to capture the full arc of the change.